Many studies have shown that in patients with insulin resistance, such as in PCOS patients, using DCI, MI, and MI plus DCI may improve insulin resistance, metabolic parameters, regularity of cycle, and spontaneous ovulation [58–63] in keeping with insulin-sensitizer effects of DCI and the role of MI in oocytes maturation. This evidence concerns the gene INS and Insulin resistance.